Capabilities
Our Digital Health group guides companies through the myriad considerations they encounter as the delivery of healthcare becomes increasingly digital.
As private equity investment in the Life Sciences and Healthcare industry continues to increase, our cohesive regulatory and transactional approach helps ensure success through each phase of investment.
We provide 360-degree support to companies that develop, manufacture and distribute products tailored specifically toward improving women’s health, from start-ups to global corporations.
Our Sunshine and State Law Compliance Group serves as a powerful industry advocate with respect to transparency laws for more than 100 members companies.
We established the Surprise Billing and Price Transparency Group to assist our clients in developing solutions to changes in healthcare transparency laws.
The K&S International Ad Hoc Group is a coalition of 20+ pharma and medical device companies that focuses on international transparency/disclosure laws targeting manufacturers.
November 19, 2025
2026 Physician Fee Schedule Final Rule Changes to ASP Calculation and Reporting Policies and Other Drug Payment Policies
October 6, 2025
Drug Ad Crackdown Demonstrates Admin's Aggressive Stance
September 19, 2025
Beaming Up Lessons From William Shatner's Failed Patent Bid
November 18, 2025
King & Spalding’s German Banking & Finance Team and Partner Ulf Grundmann Named as Finalists for 2026 Legal 500 Germany Awards
November 17, 2025
Partner John Carroll rejoins the firm’s Antitrust practice in Washington, D.C.
November 17, 2025
Antitrust Partner John Carroll Returns to King & Spalding in Washington, D.C.
November 25, 2025
King & Spalding Secures Another Victory for Boehringer Ingelheim in Zantac-Related Trial
October 10, 2025
King & Spalding Secures Significant Victory for R.J. Reynolds